Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  243.09
-3.38 (-1.37%)
AAPL  260.42
+0.17 (0.07%)
AMD  220.04
+12.35 (5.95%)
BAC  54.65
-0.54 (-0.98%)
GOOG  338.41
+5.68 (1.71%)
META  627.83
-14.14 (-2.20%)
MSFT  467.47
-9.71 (-2.03%)
NVDA  184.89
-0.05 (-0.03%)
ORCL  201.03
-3.65 (-1.78%)
TSLA  446.80
-2.16 (-0.48%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.